menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  • ReachMD Healthcare Image
    Medical News

    Mobile Teams Bring COVID-19 Vaccines to Rural Villages in Sierra Leone

  • ReachMD Healthcare Image
    Medical News

    Changes After COVID-19: Science Academies Discuss Global Health Approaches for …

  • ReachMD Healthcare Image
    Medical News

    The Big Lesson from Past Pandemics? Avoid Panic Buying, Says New Research

Programs

  • Lessons in Locum Tenens: Key Insights from the Locumstory Physician Advisory Bo…
    Spotlight on Locum Tenens

    Lessons in Locum Tenens: Key Insights from the Locumstory Physician Advisory Board

  • Idiopathic Pulmonary Fibrosis: The Role of Radiology in Accurate and Timely Dia…
    CME/CE

    Idiopathic Pulmonary Fibrosis: The Role of Radiology in Accurate and Timely Diagnosis

    1.00 credits
  • Pulmonary Arterial Hypertension: Screening, Diagnosis, and Optimizing Management
    CME/CE

    Pulmonary Arterial Hypertension: Screening, Diagnosis, and Optimizing Management

    1.00 credits
  • Experts on the Ground: New Data and Practical Clinical Integration of Therapies…
    CME/CE

    Experts on the Ground: New Data and Practical Clinical Integration of Therapies Approved for IgAN

    1.00 credits
  • The Network Effect: Analyzing Brain Structures to Treat Depression
    Medical Industry Feature

    The Network Effect: Analyzing Brain Structures to Treat Depression

  • What’s New in Treating the Anticoagulated Patient with ICH?
    CME/CE Meeting

    May 16, 2024

    13:15 - 14:45 CEST

    What’s New in Treating the Anticoagulated Patient with ICH?

Clinical Practice

  • ACC 2024: The PIONEER AF-PCI Trial
    NEW EPISODE
    MinuteCE®

    ACC 2024: The PIONEER AF-PCI Trial 

    0.50 program credits
  • Preventive PCI versus optimal medical therapy only for vulnerable plaques
    ACC Action Center

    Preventive PCI versus optimal medical therapy only for vulnerable plaques

  • What Dermatologists & Surgeons Need To Know: Adjuvant Treatment for Resectable …
    MinuteCE®

    What Dermatologists & Surgeons Need To Know: Adjuvant Treatment for Resectable Stage II Melanoma

    0.75 program credits
  • Overcoming Barriers to Timely Diagnosis and Classification of Interstitial Lung…
    CME/CE

    Overcoming Barriers to Timely Diagnosis and Classification of Interstitial Lung Disease: Considerations for Radiologists

    1.00 credits
  • Delivering Transformation: Reducing Maternal Mortality Through Systemic Change
    Medical Industry Feature

    Delivering Transformation: Reducing Maternal Mortality Through Systemic Change

  • Monitoring Treatment Reponses in CLL: A Review of Key Protocols
    Project Oncology®

    Monitoring Treatment Reponses in CLL: A Review of Key Protocols

Doctors Lounge

  • Let’s Rewind: Recognizing NAFLD/NASH in the Primary Care Clinic
    CME/CE

    Let’s Rewind: Recognizing NAFLD/NASH in the Primary Care Clinic

    0.25 credits
  • Poster Pearl: Detecting Cancer with an MCED Test and Treating It Surgically Imp…
    Project Oncology®

    Poster Pearl: Detecting Cancer with an MCED Test and Treating It Surgically Improves Outcomes

  • Poster Pearl: Imaging-Based Localization for MCED Tests Yields Lower Diagnostic…
    Project Oncology®

    Poster Pearl: Imaging-Based Localization for MCED Tests Yields Lower Diagnostic Burden

  • 25 Must-Know Medical Abbreviations
    Brain Games

    25 Must-Know Medical Abbreviations 

  • How Artificial Intelligence Is Changing the Practice of Gastroenterology
    GI Insights

    How Artificial Intelligence Is Changing the Practice of Gastroenterology

  • Op-Ed: Workplace Burnout and Physician/Medical Student Well-Being
    Op-Ed

    Op-Ed: Workplace Burnout and Physician/Medical Student Well-Being

CME

  • Understanding CIAS: What Does Current Literature Say About the Etiology and Pat…
    MinuteCE®

    Understanding CIAS: What Does Current Literature Say About the Etiology and Pathophysiology of CIAS?

    1.00 program credits
  • GPRC5D-Targeted Bispecifics in Relapsed/Refractory Multiple Myeloma: Practical …
    CME/CE

    GPRC5D-Targeted Bispecifics in Relapsed/Refractory Multiple Myeloma: Practical Expert Consensus on a New Target with Unique Adverse Events  

    0.25 credits
  • ACC 2024: What's Really New in Electrophysiology That Will Change My Practice?
    NEW EPISODE
    MinuteCE®

    ACC 2024: What's Really New in Electrophysiology That Will Change My Practice?

    0.50 program credits
  • ACC 2024: VOYAGER PAD Part 1
    NEW EPISODE
    MinuteCE®

    ACC 2024: VOYAGER PAD Part 1

    0.50 program credits
  • What Is the Acute and Post Acute Risk of VTE in Acute Medically Ill Patients?
    MinuteCE®

    What Is the Acute and Post Acute Risk of VTE in Acute Medically Ill Patients?

    1.75 program credits
  • Applying SDM to Personalize Treatment Discussions on Recurrence Risk Reduction …
    CME/CE

    Applying SDM to Personalize Treatment Discussions on Recurrence Risk Reduction in Patients with Early-Stage Melanoma

    0.25 credits

Industry Feature

  • Against the Odds: Improving Survival for Children with Pulmonary Vein Stenosis
    Medical Industry Feature

    Against the Odds: Improving Survival for Children with Pulmonary Vein Stenosis

  • Deep Learner: Building AI to Improve Cardiovascular Care
    Medical Industry Feature

    Deep Learner: Building AI to Improve Cardiovascular Care

  • Advancing the Science of Anemia Due to CKD
    Medical Industry Feature

    Advancing the Science of Anemia Due to CKD

  • Addressing Treatment Gaps Among Patients with MDS-Associated Anemia
    Medical Industry Feature

    Addressing Treatment Gaps Among Patients with MDS-Associated Anemia

  • Latest Results of a Head-to-Head Study of Two HIV-1 Treatments
    Medical Industry Feature

    Latest Results of a Head-to-Head Study of Two HIV-1 Treatments

  • Managing Refractory Cytomegalovirus After Hematopoietic Cell Transplant
    Medical Industry Feature

    Managing Refractory Cytomegalovirus After Hematopoietic Cell Transplant

Schedule8 May 2024